Screener / SEC EDGAR /CIK 0001727196 /10-K filed Mar 3, 2026, compared with Feb 27, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Biotechnology

Scholar Rock Holding Corp SRRK

Compare with peers Embed
Insider trades since May 20, 2026

Insiders bought $12.0M and sold $923K on the market

Form 4
Bought on the market $12.0M 6 trades by 1 insider
Sold on the market $923K 13 trades by 5 insiders
Sold under a 10b5-1 plan 100% of the value sold, under a plan set up in advance
Traded the most Srinivas Akkaraju $12.0M Director

Open-market buys and sales are the trades an insider chose to make. Grants, option exercises and shares withheld for tax are pay; they show under All.

A year of insider trades, day by day

Open-market buys and sales by officers and directors · Form 4, since Nov 24, 2025

NovDecJanFebMarAprMayJunJulAugSepOctNov Mon Wed Fri

$12.0M bought on 2 days, $923K sold on 1 day. Each square is a day; click one for its Form 4.

SoldBought

Buys and sales by insider

Who traded · Form 4, added up

InsiderBoughtSoldLatest
Srinivas Akkaraju
Director
$12.0M- Oct 26, 2026
Katie Peng
Director
-$293K Jul 1, 2026
Jeffrey S. Flier
Director
-$164K Jul 1, 2026
Joshua Reed
Director
-$164K Jul 1, 2026
Kristina Burow
Director
-$164K Jul 1, 2026
Michael Gilman
Director
-$137K Jul 1, 2026

Owned after: shares held right after the person's latest buy or sale, from the Form 4 the date links to. % of shares: that holding over the shares outstanding on the latest cover page. Only people who bought or sold in this period are listed, and options, restricted units and shares held by others are not counted, so the rows are not a total of what insiders own.

Trade by trade, newest first

Every trade · each date links to its Form 4

Of 13 open-market sales by officers and directors, 0 came in the 30 days before a 10-Q, a 10-K or a results 8-K. Of 6 buys, 6. Dates only, from the filing index; most companies close the window for insider trades in the weeks before results, so a trade there is often under a 10b5-1 plan.

DateInsiderTypeSharesValue
Oct 26, 2026 Srinivas Akkaraju (indirect) Buy 48,988 2.0M
Oct 26, 2026 Srinivas Akkaraju (indirect) Buy 97,982 4.1M
Oct 23, 2026 Srinivas Akkaraju (indirect) Buy 47,000 1.9M
Oct 23, 2026 Srinivas Akkaraju (indirect) Buy 94,000 3.9M
Oct 23, 2026 Srinivas Akkaraju (indirect) Buy 500 21K
Oct 23, 2026 Srinivas Akkaraju (indirect) Buy 1,000 42K
Jul 1, 2026 Katie Peng Sale (10b5-1) -2,988 160K
Jul 1, 2026 Katie Peng Sale (10b5-1) -2,437 132K
Jul 1, 2026 Katie Peng Sale (10b5-1) -21 1K
Jul 1, 2026 Joshua Reed Sale (10b5-1) -2,105 113K
Jul 1, 2026 Joshua Reed Sale (10b5-1) -948 51K
Jul 1, 2026 Kristina Burow Sale (10b5-1) -2,105 113K
Jul 1, 2026 Kristina Burow Sale (10b5-1) -948 51K
Jul 1, 2026 Michael Gilman Sale (10b5-1) -1,346 72K
Jul 1, 2026 Michael Gilman Sale (10b5-1) -1,155 63K
Jul 1, 2026 Michael Gilman Sale (10b5-1) -43 2K
Jul 1, 2026 Jeffrey S. Flier Sale (10b5-1) -1,568 84K
Jul 1, 2026 Jeffrey S. Flier Sale (10b5-1) -1,470 80K
Jul 1, 2026 Jeffrey S. Flier Sale (10b5-1) -15 823
Show the other 4 trades

Sources

Form 4s from SEC's filing index. An insider files one within two business days of a trade.

Also

Insider selling plans: the 10b5-1 plans and Form 144 notices behind planned sales.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/SRRK/export.csv") into a cell.

Next:Insider selling plans
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.